Scholarly Works

Switching Patients From Blinded Study Drug to...

Journal article

Switching Patients From Blinded Study Drug to Warfarin at the End of the ENGAGE AF–TIMI 48 Trial Setting a New Standard∗

Authors

Eikelboom JW; Vanassche T; Connolly SJ

Journal

Journal of the American College of Cardiology, Vol. 64, No. 6, pp. 585–587

Publisher

Elsevier

Publication Date

August 12, 2014

DOI

10.1016/j.jacc.2014.06.008

ISSN

0735-1097

Associated Experts

John Eikelboom

Professor, FHSMED

Labels

Fields of Research (FoR)

3214 Pharmacology and Pharmaceutical Sciences 32 Biomedical and Clinical Sciences 3201 Cardiovascular medicine and haematology

Medical Subject Headings (MeSH)

Anticoagulants Atrial Fibrillation Drug Substitution Female Humans Male Myocardial Infarction

View published work (Non-McMaster Users)

View published work (McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback